tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market
Advertisement

Immuno-Biological Laboratories Co., Ltd. (4570) Ratios

Compare
0 Followers

Immuno-Biological Laboratories Co., Ltd. Ratios

JP:4570's free cash flow for Q4 2024 was ¥0.67. For the 2024 fiscal year, JP:4570's free cash flow was decreased by ¥ and operating cash flow was ¥0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.83 4.90 4.62 4.95 7.76
Quick Ratio
3.67 3.65 3.36 3.52 5.61
Cash Ratio
3.02 2.85 2.44 2.23 4.17
Solvency Ratio
0.79 0.54 -1.39 -1.19 -1.86
Operating Cash Flow Ratio
0.00 0.52 0.10 -0.41 -1.34
Short-Term Operating Cash Flow Coverage
0.00 0.88 0.19 -0.72 -6.26
Net Current Asset Value
¥ 1.10B¥ 908.85M¥ 809.57M¥ 792.80M¥ 916.21M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.15 0.16 0.14 0.05
Debt-to-Equity Ratio
0.13 0.19 0.22 0.17 0.06
Debt-to-Capital Ratio
0.11 0.16 0.18 0.15 0.05
Long-Term Debt-to-Capital Ratio
0.02 0.06 0.08 0.07 0.03
Financial Leverage Ratio
1.22 1.28 1.33 1.25 1.13
Debt Service Coverage Ratio
1.60 1.25 -2.49 -1.99 -10.02
Interest Coverage Ratio
160.90 92.30 54.40 -190.67 -321.74
Debt to Market Cap
0.04 0.05 0.06 0.08 0.02
Interest Debt Per Share
21.29 25.46 25.35 25.19 9.74
Net Debt to EBITDA
-3.14 -3.89 1.14 1.10 1.66
Profitability Margins
Gross Profit Margin
66.40%63.34%66.28%58.17%57.55%
EBIT Margin
22.33%15.40%-35.18%-38.53%-51.41%
EBITDA Margin
23.66%15.69%-41.78%-38.53%-51.41%
Operating Profit Margin
22.28%12.77%7.35%-18.87%-39.98%
Pretax Profit Margin
22.15%15.26%-35.31%-38.63%-51.54%
Net Profit Margin
27.17%22.86%-36.46%-39.96%-52.90%
Continuous Operations Profit Margin
27.17%22.86%-36.46%-39.96%-52.90%
Net Income Per EBT
122.66%149.78%103.25%103.45%102.64%
EBT Per EBIT
99.43%119.51%-480.72%204.67%128.90%
Return on Assets (ROA)
13.48%11.53%-20.20%-15.17%-17.35%
Return on Equity (ROE)
17.76%14.75%-26.86%-18.91%-19.57%
Return on Capital Employed (ROCE)
13.10%7.66%4.94%-8.27%-14.23%
Return on Invested Capital (ROIC)
14.55%10.33%4.57%-7.87%-14.35%
Return on Tangible Assets
13.49%11.55%-20.20%-15.17%-17.35%
Earnings Yield
5.83%3.89%-7.64%-8.50%-6.20%
Efficiency Ratios
Receivables Turnover
5.26 4.29 3.67 3.72 3.03
Payables Turnover
46.24 68.91 47.03 68.93 35.31
Inventory Turnover
0.92 0.93 0.84 0.83 0.82
Fixed Asset Turnover
4.62 6.01 6.66 5.39 4.74
Asset Turnover
0.50 0.50 0.55 0.38 0.33
Working Capital Turnover Ratio
0.84 0.85 0.88 0.69 0.55
Cash Conversion Cycle
456.95 472.19 524.86 532.77 553.69
Days of Sales Outstanding
69.44 85.05 99.36 98.00 120.47
Days of Inventory Outstanding
395.41 392.44 433.26 440.06 443.56
Days of Payables Outstanding
7.89 5.30 7.76 5.30 10.34
Operating Cycle
464.85 477.49 532.63 538.06 564.03
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 14.36 2.84 -10.01 -20.85
Free Cash Flow Per Share
0.00 12.36 2.84 -10.01 -22.29
CapEx Per Share
0.00 2.00 0.00 0.00 1.45
Free Cash Flow to Operating Cash Flow
0.00 0.86 1.00 1.00 1.07
Dividend Paid and CapEx Coverage Ratio
0.00 7.17 0.00 0.00 -14.42
Capital Expenditure Coverage Ratio
0.00 7.17 0.00 0.00 -14.42
Operating Cash Flow Coverage Ratio
0.00 0.57 0.11 -0.40 -2.16
Operating Cash Flow to Sales Ratio
0.00 0.16 0.03 -0.14 -0.32
Free Cash Flow Yield
0.00%2.40%0.70%-3.06%-4.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.21 25.69 -13.08 -11.77 -16.12
Price-to-Sales (P/S) Ratio
4.68 5.87 4.77 4.70 8.53
Price-to-Book (P/B) Ratio
2.83 3.79 3.51 2.23 3.16
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 41.67 143.27 -32.68 -24.76
Price-to-Operating Cash Flow Ratio
0.00 35.85 143.27 -32.68 -26.48
Price-to-Earnings Growth (PEG) Ratio
4.48 -0.16 -1.09 0.62 0.29
Price-to-Fair Value
2.83 3.79 3.51 2.23 3.16
Enterprise Value Multiple
16.63 33.55 -10.28 -11.11 -14.93
Enterprise Value
3.73B 4.30B 3.41B 2.77B 4.63B
EV to EBITDA
16.55 33.55 -10.28 -11.11 -14.93
EV to Sales
3.91 5.26 4.29 4.28 7.68
EV to Free Cash Flow
0.00 37.34 128.94 -29.73 -22.29
EV to Operating Cash Flow
0.00 32.13 128.94 -29.73 -23.83
Tangible Book Value Per Share
168.96 135.61 115.81 146.92 174.94
Shareholders’ Equity Per Share
169.14 135.86 115.81 146.92 174.94
Tax and Other Ratios
Effective Tax Rate
-0.23 -0.50 -0.03 -0.03 -0.03
Revenue Per Share
102.21 87.69 85.32 69.53 64.72
Net Income Per Share
27.77 20.05 -31.11 -27.78 -34.23
Tax Burden
1.23 1.50 1.03 1.03 1.03
Interest Burden
0.99 0.99 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.16 0.23 0.29 0.44
SG&A to Revenue
0.05 <0.01 0.01 <0.01 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.72 -0.09 0.37 0.63
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis